Real-time, high-resolution imaging of tumor cells in genetically engineered and orthotopic models of thyroid cancer.


Journal

Endocrine-related cancer
ISSN: 1479-6821
Titre abrégé: Endocr Relat Cancer
Pays: England
ID NLM: 9436481

Informations de publication

Date de publication:
10 2020
Historique:
received: 08 07 2020
accepted: 13 07 2020
pubmed: 23 7 2020
medline: 29 9 2021
entrez: 23 7 2020
Statut: ppublish

Résumé

Genetically engineered and orthotopic xenograft mouse models have been instrumental for increasing our understanding of thyroid cancer progression and for the development of novel therapeutic approaches in a setting that is more physiologically relevant than the classical subcutaneous flank implants. However, the anatomical location of the thyroid gland precludes a non-invasive analysis at the cellular level of the interactions between tumor cells and the surrounding microenvironment and does not allow a real-time evaluation of the response of tumor cells to drug treatments. As a consequence, such studies have generally only relied on endpoint approaches, limiting the amount and depth of the information that could be gathered. Here we describe the development of an innovative approach to imaging specific aspects of thyroid cancer biology, based on the implantation of a permanent, minimally invasive optical window that allows high-resolution, multi-day, intravital imaging of the behavior and cellular dynamics of thyroid tumors in the mouse. We show that this technology allows visualization of fluorescently tagged tumor cells both in immunocompetent, genetically engineered mouse models of anaplastic thyroid cancer (ATC) and in immunocompromised mice carrying orthotopic implanted human or mouse ATC cells. Furthermore, the use of recipient mice in which endothelial cells and macrophages are fluorescently labeled allows the detection of the spatial and functional relationship between tumor cells and their microenvironment. Finally, we show that ATC cells expressing a fluorescent biosensor for caspase 3 activity can be effectively utilized to evaluate, in real-time, the efficacy and kinetics of action of novel small molecule therapeutics. This novel approach to intravital imaging of thyroid cancer represents a platform that will allow, for the first time, the longitudinal, in situ analysis of tumor cell responses to therapy and of their interaction with the microenvironment.

Identifiants

pubmed: 32698130
doi: 10.1530/ERC-20-0295
pii: ERC-20-0295
pmc: PMC7450603
mid: NIHMS1618174
doi:
pii:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

529-539

Subventions

Organisme : NCI NIH HHS
ID : P30 CA013330
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA128943
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA216248
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA200561
Pays : United States

Références

J Leukoc Biol. 2008 Feb;83(2):430-3
pubmed: 17971498
J Orthop Res. 2011 Aug;29(8):1251-8
pubmed: 21381098
Proc Natl Acad Sci U S A. 2019 Jul 9;116(28):14254-14259
pubmed: 31235603
J Clin Invest. 2016 Mar 1;126(3):1052-66
pubmed: 26878173
Oncogene. 2018 Aug;37(32):4475-4488
pubmed: 29743589
Nat Med. 2019 Apr;25(4):641-655
pubmed: 30936549
Nat Commun. 2018 Dec 17;9(1):5341
pubmed: 30559424
Cytometry A. 2020 May;97(5):448-457
pubmed: 31889408
Cancer Lett. 2015 Nov 1;368(1):7-13
pubmed: 26276713
Oncotarget. 2011 Dec;2(12):1109-26
pubmed: 22190384
Methods Mol Biol. 2018;1763:129-136
pubmed: 29476494
Endocr Relat Cancer. 2019 Jun;26(6):R319-R344
pubmed: 30978703
J Am Chem Soc. 2019 Mar 20;141(11):4526-4530
pubmed: 30821975
Intravital. 2013 Apr 1;2(2):e25294
pubmed: 25013744
Int J Mol Sci. 2019 Sep 07;20(18):
pubmed: 31500315
Cell Rep. 2018 Jun 12;23(11):3312-3326
pubmed: 29898401
J Cell Mol Med. 2017 Nov;21(11):3044-3054
pubmed: 28557288
Breast Cancer Res. 2019 Jan 24;21(1):12
pubmed: 30678714
PLoS One. 2013 Jul 25;8(7):e69658
pubmed: 23936067
J Appl Physiol (1985). 2008 Feb;104(2):338-46
pubmed: 18006870
Cancer Discov. 2018 Dec;8(12):1598-1613
pubmed: 30254092
J Mammary Gland Biol Neoplasia. 2012 Jun;17(2):125-9
pubmed: 22581273
Nat Methods. 2018 Jan;15(1):73-80
pubmed: 29176592
Cancer Discov. 2015 Jan;5(1):35-42
pubmed: 25312016
Sci Transl Med. 2017 Apr 5;9(384):
pubmed: 28381539
Intravital. 2016 Jul 25;5(3):e1215789
pubmed: 28243521
Thyroid. 2020 May 8;:
pubmed: 32284020
Thyroid. 2009 Oct;19(10):1077-84
pubmed: 19772429
Dev Cell. 2017 Sep 11;42(5):542-553.e4
pubmed: 28826819
Curr Protoc Cell Biol. 2013 Mar;Chapter 19:Unit19.7
pubmed: 23456602
Semin Nephrol. 2018 Jan;38(1):52-62
pubmed: 29291762
Cancer Lett. 2017 Feb 28;387:61-68
pubmed: 26845449
J Exp Med. 2013 Jul 29;210(8):1509-28
pubmed: 23878309
Curr Drug Discov Technol. 2015;12(1):3-20
pubmed: 26033233
Curr Drug Discov Technol. 2015;12(4):218-24
pubmed: 26778084
Methods. 2017 Sep 1;128:65-77
pubmed: 28911733
Sci Transl Med. 2012 Oct 31;4(158):158ra145
pubmed: 23115354
Cytometry A. 2020 May;97(5):528-539
pubmed: 31423731
Mol Cancer. 2018 Oct 23;17(1):154
pubmed: 30352606

Auteurs

Xhesika Shanja-Grabarz (X)

Department of Developmental and Molecular Biology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York, USA.

Anouchka Coste (A)

Department of Anatomy and Structural Biology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York, USA.

David Entenberg (D)

Department of Anatomy and Structural Biology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York, USA.

Antonio Di Cristofano (A)

Department of Developmental and Molecular Biology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH